Europe Cerebrospinal Fluid Management Market Forecast to 2030

Europe Cerebrospinal Fluid Management Market Forecast to 2030 – Regional Analysis – by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

Send Enquiry

$2,485$3,885

Description

The Europe cerebrospinal fluid management market was valued at US$ 544.31 million in 2022 and is expected to reach US$ 817.12 million by 2030; it is estimated to grow at a CAGR of 5.2% from 2022 to 2030.

R&D in the Field of CSF Management Fuels the Europe Cerebrospinal Fluid Management Market

R&D in the field of CSF management in the region is marked by a commitment to advancing medical knowledge, improving patient outcomes, and enhancing treatment modalities. European countries are renowned for their robust investments in healthcare research and innovation, making significant contributions to the field of CSF management. For example, research institutions and universities collaborate on projects aimed at improving CSF shunt systems, which are pivotal in the treatment of conditions like hydrocephalus. These collaborations often result in innovative designs, materials, and minimally invasive techniques that reduce complications and improve patient quality of life.

Furthermore, Europe is at the forefront of clinical trials related to CSF-related disorders. These trials focus on the development of novel diagnostic tools and treatments for conditions such as idiopathic intracranial hypertension (IIH) or normal pressure hydrocephalus (NPH). For instance, the ongoing research into the diagnostic criteria and treatment options for NPH is shaping the standard of care for patients. Additionally, biomarker research is advancing the ability to diagnose through cerebrospinal fluid analysis. These initiatives represent the region’s focus on advancing CSF management. Thus, it is expected to bolster the growth of the market during the coming years.

Europe Cerebrospinal Fluid Management Market Overview

The Europe cerebrospinal fluid management market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Countries such as Germany and the UK are expected to be the largest contributors to the market in this region. The rising prevalence of iNPH and malignant CNS tumors are the major factors driving the growth of this market in Europe.

Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)

Europe Cerebrospinal Fluid Management Market Segmentation

The Europe cerebrospinal fluid management market is segmented into product, end user and country.

Based on product, the Europe cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held a larger market share in 2022.

Based on end user, the Europe cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Europe cerebrospinal fluid management market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe cerebrospinal fluid management market share in 2022.

Argi Group Health Services Ltd Sti, B. Braun SE, Delta Surgical Ltd, Integra LifeSciences Holdings Corp, Medtronic Plc, Moller Medical GmbH, Natus Medical Inc, Sophysa SA, and Spiegelberg GmbH & Co KG are some of the leading companies operating in the Europe cerebrospinal fluid management market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 5.2% CAGR, the Europe Cerebrospinal Fluid Management Market is speculated to be worth US$ 817.12 million by 2030, says The Research Team

According to The Research Team’ research, the Europe cerebrospinal fluid management market was valued at US$ 544.31 million in 2022 and is expected to reach US$ 817.12 million by 2030, registering a CAGR of 5.2% from 2022 to 2030. Increasing cases of cerebrospinal fluid leak is among the critical factors attributed to the Europe cerebrospinal fluid management market expansion.

CSF parameters are extensively evaluated as biomarkers of neurological disorders in adult patients. Circulating microRNAs in CSF are a promising class of biomarkers for the diagnosis of various neurological diseases. Neurological disorders such as Parkinson’s Disease (PD), Alzheimer’s Disease (AD), epilepsy, and seizures often lead to altered CSF parameters. According to an article published in Nature, 76 CSF proteins were found to be structurally altered in patients that were diagnosed with PD when compared to normal individuals. The study also suggests that these CSF proteins can be used as biomarkers for the diagnosis or treatment of the disease. PD is a neurodegenerative disease associated with loss of cognitive impairment and motor function. According to the World Health Organization (WHO) report published in 2022, the prevalence of PD has doubled in the last 25 years, affecting ~1% of the global population aged more than 60 years. Similarly, a few of the CSF parameters such as protein and lactate levels are altered in patients suffering from seizure or status epilepticus. Therefore, various R&D activities are going on for using CSF parameters in the treatment of seizures or epilepsy. Further, despite the availability of various CSF assays for the detection of Alzheimer’s disease using CSF in the market, there are unmet needs for biomarkers for detection and treatment purposes. As the detection of cases of Alzheimer’s disease and PD increases, there is increase in demand for CSF management devices as the cases of CSF leaks may increases. Therefore, a rise in the prevalence of neurological disorders is fueling the research and development activities for the use of CSF management products in the treatment of these disorders.

On the contrary, risk of failure and malfunctioning hampers on the growth of Europe cerebrospinal fluid management market.

Based on product, the Europe cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held 87.3% share of Europe cerebrospinal fluid management market in 2022, amassing US$ 475.38 million. It is projected to garner US$ 724.31 million by 2030 to expand at 5.4% CAGR during 2022–2030.

Based on end user, the Europe cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held 56.8% share of Europe cerebrospinal fluid management market in 2022, amassing US$ 309.39 million. It is projected to garner US$ 479.02 million by 2030 to expand at 5.6% CAGR during 2022–2030.

Based on country, the Europe cerebrospinal fluid management market has been categorized into the U.K., Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 24.9% share of Europe cerebrospinal fluid management market in 2022. It was assessed at US$ 135.55 million in 2022 and is likely to hit US$ 209.26 million by 2030, exhibiting a CAGR of 5.6% during 2022–2030.

Key players operating in the Europe cerebrospinal fluid management market are Argi Group Health Services Ltd Sti, B. Braun SE, Delta Surgical Ltd, Integra LifeSciences Holdings Corp, Medtronic Plc, Moller Medical GmbH, Natus Medical Inc, Sophysa SA, and Spiegelberg GmbH & Co KG, among others.

In 2023, The Möller Medical GmbH had recalled some of a lot of Drainage Set LiquoGuard 7 as leakage was detected in the course of use in isolated cases as part of its ongoing quality and market monitoring processes.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe cerebrospinal fluid management market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Europe cerebrospinal fluid management market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Cerebrospinal Fluid Management Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
5. Europe Cerebrospinal Fluid Management Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Cases of Cerebrospinal Fluid Leaks
5.1.2 R&D in the Field of CSF Management
5.2 Market Restraints
5.2.1 Risk of Failure and Malfunctioning
5.3 Market Opportunities
5.3.1 Increasing Focus on CSF Management in Neurological Disease Treatments
5.4 Future Trends
5.4.1 Development of Smart Cerebrospinal Fluid Shunts
5.5 Impact Analysis:
6. Cerebrospinal Fluid Management Market – Europe Market Analysis
6.1 Europe Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 – 2030
7. Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Europe Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
7.3 CSF Shunts
7.3.1 Overview
7.3.2 CSF Shunts: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.3.3 Ventriculoperitoneal Shunts
7.3.3.1 Overview
7.3.3.2 Ventriculoperitoneal Shunts: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.3.4 Ventriculoatrial Shunts
7.3.4.1 Overview
7.3.4.2 Ventriculoatrial Shunts: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.3.5 Ventriculopleural Shunts
7.3.5.1 Overview
7.3.5.2 Ventriculopleural Shunts: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.3.6 Lumboperitoneal Shunts
7.3.6.1 Overview
7.3.6.2 Lumboperitoneal Shunts: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.4 CSF Drainage Systems
7.4.1 Overview
7.4.2 CSF Drainage Systems: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.4.3 External Ventricular Drainage (EVD) Systems
7.4.3.1 Overview
7.4.3.2 External Ventricular Drainage (EVD) Systems: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.4.4 Lumbar Drainage (LD) Systems
7.4.4.1 Overview
7.4.4.2 Lumbar Drainage (LD) Systems: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 – by End User
8.1 Overview
8.2 Europe Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Clinics
8.4.1 Overview
8.4.2 Clinics: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Ambulatory Surgical Centers
8.5.1 Overview
8.5.2 Ambulatory Surgical Centers: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Cerebrospinal Fluid Management Market – Country Analysis
9.1 Overview
9.1.1.1 Europe Cerebrospinal Fluid Management Market, by Country
9.1.1.2 UK
9.1.1.2.1 Overview
9.1.1.2.2 UK: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.2.3 UK: Europe Cerebrospinal Fluid Management Market, by Product
9.1.1.2.3.1 UK: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.1.2.3.2 UK: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.1.2.4 UK: Europe Cerebrospinal Fluid Management Market, by End User
9.1.1.3 Germany
9.1.1.3.1 Overview
9.1.1.3.2 Germany: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.3.3 Germany: Europe Cerebrospinal Fluid Management Market, by Product
9.1.1.3.3.1 Germany: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.1.3.3.2 Germany: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.1.3.4 Germany: Europe Cerebrospinal Fluid Management Market, by End User
9.1.1.4 France
9.1.1.4.1 Overview
9.1.1.4.2 France: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.4.3 France: Europe Cerebrospinal Fluid Management Market, by Product
9.1.1.4.3.1 France: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.1.4.3.2 France: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.1.4.4 France: Europe Cerebrospinal Fluid Management Market, by End User
9.1.1.5 Italy
9.1.1.5.1 Overview
9.1.1.5.2 Italy: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.5.3 Italy: Europe Cerebrospinal Fluid Management Market, by Product
9.1.1.5.3.1 Italy: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.1.5.3.2 Italy: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.1.5.4 Italy: Europe Cerebrospinal Fluid Management Market, by End User
9.1.1.6 Spain
9.1.1.6.1 Overview
9.1.1.6.2 Spain: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.6.3 Spain: Europe Cerebrospinal Fluid Management Market, by Product
9.1.1.6.3.1 Spain: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.1.6.3.2 Spain: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.1.6.4 Spain: Europe Cerebrospinal Fluid Management Market, by End User
9.1.1.7 Rest of Europe
9.1.1.7.1 Overview
9.1.1.7.2 Rest of Europe: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.7.3 Rest of Europe: Europe Cerebrospinal Fluid Management Market, by Product
9.1.1.7.3.1 Rest of Europe: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.1.7.3.2 Rest of Europe: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.1.7.4 Rest of Europe: Europe Cerebrospinal Fluid Management Market, by End User
10. Europe Cerebrospinal Fluid Management Market –Industry Landscape
10.1 Overview
10.2 Growth Strategies in The Europe Cerebrospinal Fluid Management Market, 2020-2023
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Medtronic Plc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Integra LifeSciences Holdings Corp
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 B. Braun SE
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Argi Group Health Services Ltd Sti
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Sophysa SA
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Delta Surgical Ltd
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Moller Medical GmbH
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Natus Medical Inc
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Spiegelberg GmbH & Co KG
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Cerebrospinal Fluid Management Market Segmentation
Table 2. UK: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 3. UK: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Shunts
Table 4. UK: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Drainage Systems
Table 5. UK: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 6. Germany: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 7. Germany: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Shunts
Table 8. Germany: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Drainage Systems
Table 9. Germany: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 10. France: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 11. France: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Shunts
Table 12. France: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Drainage Systems
Table 13. France: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 14. Italy: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 15. Italy: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Shunts
Table 16. Italy: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Drainage Systems
Table 17. Italy: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 18. Spain: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 19. Spain: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Shunts
Table 20. Spain: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Drainage Systems
Table 21. Spain: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 22. Rest of Europe: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 23. Rest of Europe: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Shunts
Table 24. Rest of Europe: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Drainage Systems
Table 25. Rest of Europe: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 26. Recent Inorganic Growth Strategies in the Europe Cerebrospinal Fluid Management Market
Table 27. Recent Organic Growth Strategies in The Europe Cerebrospinal Fluid Management Market
Table 28. Glossary of Terms, Europe Cerebrospinal Fluid Management Market

LIST OF FIGURES

Figure 1. Europe Cerebrospinal Fluid Management Market Segmentation, By Country
Figure 2. Europe – PEST Analysis
Figure 3. Europe Cerebrospinal Fluid Management Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Europe Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Europe Cerebrospinal Fluid Management Market Revenue, Country (US$ Mn), 2022 – 2030
Figure 7. Europe Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
Figure 8. CSF Shunts: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Ventriculoperitoneal Shunts: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Ventriculoatrial Shunts: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Ventriculopleural Shunts: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Lumboperitoneal Shunts: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. CSF Drainage Systems: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. External Ventricular Drainage (EVD) Systems: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Lumbar Drainage (LD) Systems: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Europe Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
Figure 17. Hospitals: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Clinics: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Ambulatory Surgical Centers: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: Europe Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Europe Cerebrospinal Fluid Management Market, By Key Country- Revenue (2022) ($Mn)
Figure 22. Europe Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
Figure 23. UK: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Germany: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. France: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Italy: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Spain: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Rest of Europe: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Growth Strategies in The Europe Cerebrospinal Fluid Management Market, 2020-2023

The List of Companies – Europe Cerebrospinal Fluid Management Market

o Argi Group Health Services Ltd Sti
o B. Braun SE
o Delta Surgical Ltd
o Integra LifeSciences Holdings Corp
o Medtronic Plc
o Moller Medical GmbH
o Natus Medical Inc
o Sophysa SA
o Spiegelberg GmbH & Co KG

Reviews

There are no reviews yet.

Be the first to review “Europe Cerebrospinal Fluid Management Market Forecast to 2030”